3 Biotech Stocks With Huge Catalysts Incoming

Right now, investors are waiting for news from BeyondSpring (NASDAQ: BYSI), Allakos (NASDAQ: ALLK), and Deciphera Pharmaceuticals (NASDAQ: DCPH) that could send their stock prices screaming higher, or lower, overnight. Shares of BeyondSpring more than tripled in August after the clinical-stage biotech's lead candidate, plinabulin, produced positive results. During a clinical trial with lung cancer patients called Dublin-3, adding plinabulin to standard chemotherapy significantly reduced patients' risk of death.